Discover your future in Internal Medicine

The General Internist Career Path

Internal Medicine physicians are specialists who apply scientific knowledge and clinical expertise to the diagnosis, treatment, and compassionate care of adults across the spectrum from health to complex illness.

More About Internal Medicine Careers

The Subspecialist Career Path

Subspecialists in internal medicine have chosen to receive additional, more in-depth training and board certification in the diagnosis and management of diseases of a specific type or diseases affecting a single organ system.

More About Subspecialty Careers

The Hospitalist Career Path

Hospitalists are providers who dedicate most of their career to the care of hospitalized patients. They focus on clinical management, with an added eye to quality, safety, and utilization.

More About Hospitalist Careers

My Kind of Medicine:
Real Stories of ACP Internists

Farzanna S. Haffizulla, MD, FACP

Dr. Farzanna S. Haffizulla

Internist in Private Practice

Saad Z. Usmani

Dr. Saad Z. Usmani

Director of Clinical Research

Joshua M. Liao, MD

Dr. Joshua M. Liao

Internal Medicine Resident

Saad Z. Usmani

Dr. Saad Z. Usmani

Director of Clinical Research

Joshua M. Liao, MD

Dr. Joshua M. Liao

Internal Medicine Resident

Dr. Valerie J. Lang

Dr. Valerie J. Lang

Associate Professor of Medicine

Dr. David Fleming

Dr. David Fleming

ACP President with Dr. Robert Centor, ACP Chair, Board of Regents

Dr. Kent J. DeZee

Dr. Kent DeZee

Program Director, General Medicine Fellowship

Dr. Erik Wallace

Dr. Erik Wallace

Associate Dean

Dr. Suchitra Behl

Dr. Suchitra Behl

Consultant for FORTIS C-DOC

Dr. Aysha Khoury

Dr. Aysha Khoury

Clinical Decision Unit Internist

Take Action
Join us on the Hill

  1. Join the Advocates for Internal Medicine Network and make a difference on Capitol Hill.
  2. Login to the Legislative Action Center and be heard by policy makers.
  3. Follow The Advocacy Blog and get the latest news and opinions on health care reform.
Challenge your mind…

HEADLINES from ACP:

MORE NEWS
MKSAP 5 - Question of the Week

A 54-year-old woman is evaluated in the emergency department for jaw and shoulder pain that has occurred intermittently for the past week. The symptoms occur with activity and are relieved by rest. Medical and family history is unremarkable. She is not taking any medications.

Physical examination shows a blood pressure of 150/68 mm Hg and a pulse of 90/min. There is no jugular venous distention and carotid upstrokes are normal. There are no cardiac murmurs and the lung fields are clear. Extremities show no edema and peripheral pulses are normal bilaterally. The troponin I level is elevated.

Electrocardiogram shows 1.0-mm ST-segment depression in leads V1 through V4 with T-wave inversions.

The patient is given aspirin, intravenous nitroglycerin, low-molecular-weight heparin, clopidogrel, and atorvastatin.

The most appropriate additional treatment for this patient is metoprolol. This patient's elevated troponin I level and ST-segment depression and T-wave inversions on electrocardiogram are indicative of a non–ST-elevation myocardial infarction (NSTEMI). Early intravenous β-blocker therapy reduces infarct size, decreases the frequency of recurrent myocardial ischemia, and improves short- and long-term survival. β-Blockers diminish myocardial oxygen demand by reducing heart rate, systemic arterial pressure, and myocardial contractility; in addition, prolongation of diastole augments perfusion to the injured myocardium. β-Blocker therapy can be used in left ventricular dysfunction if heart failure status is stable.

An intra-aortic balloon pump is indicated for an acute coronary syndrome with cardiogenic shock that is unresponsive to medical therapy, acute mitral regurgitation secondary to papillary muscle dysfunction, ventricular septal rupture, or refractory angina. The intra-aortic balloon pump reduces afterload during ventricular systole and increases coronary perfusion during diastole. Patients with refractory cardiogenic shock who are treated with an intra-aortic balloon pump have a lower in-hospital mortality rate than patients who are not treated. This patient has no indication for an intra-aortic balloon pump.

Calcium channel blockers, such as verapamil, are also effective antianginal medications, but data are conflicting as to whether calcium channel blockers reduce mortality in patients with NSTEMI. Therefore, β-blockers are first-line therapy for unstable angina and NSTEMI unless contraindications are present. With ongoing ischemia despite β-blocker therapy, a calcium channel blocker can be added. However, there is no indication for starting verapamil rather than metoprolol at this time.

There is no role for the routine use of warfarin in the treatment of acute coronary syndrome, including NSTEMI. Warfarin is not associated with improved patient outcome as compared to treatment without warfarin. Warfarin may be considered in patients at increased risk for thromboembolism, such as those with atrial fibrillation.

Key Point

  • In patients with myocardial infarction, early intravenous β-blocker therapy reduces infarct size, decreases the frequency of recurrent myocardial ischemia, and improves short- and long-term survival.
Q. Which of the following is the most appropriate additional immediate treatment for this patient?
Abstract Competition

Abstract Competition

The College sponsors local and national abstract competitions especially for student members that offer monetary awards and the chance to win recognition.

Doctor's Dilemma

Doctor's Dilemma™

ACP's national medical jeopardy competition, held each year at ACP’s annual meeting, allows dozens of teams of residents and medical students from around the nation to compete for the coveted title of national champion.

Member Benefits

Discover the benefits of ACP membership that are waiting for you.

Shop ACP Online

MKSAP for Students 5 Digital

MKSAP for Students 5 Digital

List: $69.95
Student Member: $59.95

Internal Medicine Essentials

Internal Medicine Essentials for Students

List: $54.95
Student Member: $44.95

MKSAP for Students 5 Book

MKSAP for Students 5 Book

List: $54.95
Student Member: $44.95

On Being a Doctor 3

On Being a Doctor 3

List: $29.95
Member: $24.95

Ethics Manual, Sixth Edition

Ethics Manual, Sixth Edition

List: $12.95
Member: $10.95

Breaking the Cycle

Breaking the Cycle

List: $29.95
Member: $24.95